東華大學圖書館 |

Language: English

Help

回圖書館首頁

手機版館藏查詢

Back

Switch To: Labeled | MARC Mode | ISBD

Discerning the role of LMO4 as a glo...

Montanez-Wiscovich, Marjorie E.

Linked to FindBook

Google Book

Amazon

博客來

Discerning the role of LMO4 as a global modulator of G2/M cell cycle progression and centrosome cycle in breast cancer cells.

Record Type:	Language materials, printed : Monograph/item
Title/Author:	Discerning the role of LMO4 as a global modulator of G2/M cell cycle progression and centrosome cycle in breast cancer cells./
Author:	Montanez-Wiscovich, Marjorie E.
Description:	170 p.
Notes:	Source: Dissertation Abstracts International, Volume: 71-02, Section: B, page: 0947.
Contained By:	Dissertation Abstracts International71-02B.
Subject:	Biology, Cell. -
Online resource:	http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=3394978
ISBN:	9781109627152

Discerning the role of LMO4 as a global modulator of G2/M cell cycle progression and centrosome cycle in breast cancer cells.
Montanez-Wiscovich, Marjorie E.

Discerning the role of LMO4 as a global modulator of G2/M cell cycle progression and centrosome cycle in breast cancer cells. - 170 p.

Source: Dissertation Abstracts International, Volume: 71-02, Section: B, page: 0947.

Thesis (Ph.D.)--Case Western Reserve University, 2010.

A woman's lifetime risk of developing breast cancer in the United States is 1 in 8 (12.3%). Of these women, 15% will die from this disease. In an effort to understand breast cancer pathology, previous studies have shown that breast cancer is not a single disease, but one composed of three major molecular subtypes: luminal-like, ErbB2-overexpressing and basal-like cancers. The molecular classification of breast cancers has provided a starting point for the development of tailored therapies that will provide better diagnostic tools and improved treatment strategies. They have additionally supplied potential targets for the study of breast oncogenesis. The LIM-only protein 4, LMO4, is one of these targets. Analysis of gene expression data revealed that LMO4 is overexpressed in a murine model of ErbB2-overexpressing cancers compared to wild-type tissue. LMO4 is also upregulated in human basal-like breast cancers compared to other subtypes, suggesting LMO4 is a common downstream effector of several oncogenic pathways. Thus, a major emphasis of this dissertation is to investigate the role of LMO4 in the different breast cancer subtypes. Loss of LMO4 in breast cancer cell lines representing the three major subtypes revealed that LMO4 is essential for progression through G2/M, indicating LMO4 acts as a global modulator of cell cycle progression. Additionally, LMO4 is necessary for sustained expression of several genes involved in cell division such as Cyclin D1, Cyclin E and Cullin-3. When LMO4 was evaluated in breast cancers, its expression was observed in all tumors examined, regardless of subtype with increased expression in ErbB2-overexpressing and basal-like cancers. The elevated levels of LMO4 in tumors known to have high mitotic indices further suggest that LMO4 correlates with the aggressiveness of tumors. Consistent with this notion, aberrant expression of LMO4 in breast cancer cells induces centrosome amplification and abnormal mitotic spindle formation, supporting a role for LMO4 in maintaining genomic stability. Together, the work presented herein provide insight into the signaling pathways that regulate expression of LMO4 in breast cancers as well as the mechanisms utilized by LMO4 to drive breast carcinogenesis.

ISBN: 9781109627152Subjects--Topical Terms:

1017686
Biology, Cell.

Discerning the role of LMO4 as a global modulator of G2/M cell cycle progression and centrosome cycle in breast cancer cells.
LDR:03218nam 2200289 4500 001 1403504
005 20111118095942.5
008 130515s2010 ||||||||||||||||| ||eng d
020 $a 9781109627152
035 $a (UMI)AAI3394978
035 $a AAI3394978
040 $a UMI $c UMI
100 1 $a Montanez-Wiscovich, Marjorie E. $3 1682768
245 1 0 $a Discerning the role of LMO4 as a global modulator of G2/M cell cycle progression and centrosome cycle in breast cancer cells.
300 $a 170 p.
500 $a Source: Dissertation Abstracts International, Volume: 71-02, Section: B, page: 0947.
500 $a Adviser: Ruth A. Keri.
502 $a Thesis (Ph.D.)--Case Western Reserve University, 2010.
520 $a A woman's lifetime risk of developing breast cancer in the United States is 1 in 8 (12.3%). Of these women, 15% will die from this disease. In an effort to understand breast cancer pathology, previous studies have shown that breast cancer is not a single disease, but one composed of three major molecular subtypes: luminal-like, ErbB2-overexpressing and basal-like cancers. The molecular classification of breast cancers has provided a starting point for the development of tailored therapies that will provide better diagnostic tools and improved treatment strategies. They have additionally supplied potential targets for the study of breast oncogenesis. The LIM-only protein 4, LMO4, is one of these targets. Analysis of gene expression data revealed that LMO4 is overexpressed in a murine model of ErbB2-overexpressing cancers compared to wild-type tissue. LMO4 is also upregulated in human basal-like breast cancers compared to other subtypes, suggesting LMO4 is a common downstream effector of several oncogenic pathways. Thus, a major emphasis of this dissertation is to investigate the role of LMO4 in the different breast cancer subtypes. Loss of LMO4 in breast cancer cell lines representing the three major subtypes revealed that LMO4 is essential for progression through G2/M, indicating LMO4 acts as a global modulator of cell cycle progression. Additionally, LMO4 is necessary for sustained expression of several genes involved in cell division such as Cyclin D1, Cyclin E and Cullin-3. When LMO4 was evaluated in breast cancers, its expression was observed in all tumors examined, regardless of subtype with increased expression in ErbB2-overexpressing and basal-like cancers. The elevated levels of LMO4 in tumors known to have high mitotic indices further suggest that LMO4 correlates with the aggressiveness of tumors. Consistent with this notion, aberrant expression of LMO4 in breast cancer cells induces centrosome amplification and abnormal mitotic spindle formation, supporting a role for LMO4 in maintaining genomic stability. Together, the work presented herein provide insight into the signaling pathways that regulate expression of LMO4 in breast cancers as well as the mechanisms utilized by LMO4 to drive breast carcinogenesis.
590 $a School code: 0042.
650 4 $a Biology, Cell. $3 1017686
650 4 $a Health Sciences, Pharmacology. $3 1017717
650 4 $a Health Sciences, Oncology. $3 1018566
690 $a 0379
690 $a 0419
690 $a 0992
710 2 $a Case Western Reserve University. $3 1017714
773 0 $t Dissertation Abstracts International $g 71-02B.
790 1 0 $a Keri, Ruth A., $e advisor
790 $a 0042
791 $a Ph.D.
792 $a 2010
856 4 0 $u http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=3394978